Page last updated: 2024-11-11

trans-3-methyl-2-hexenoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

trans-3-methyl-2-hexenoic acid: schizophrenic odor factor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(2E)-3-methylhex-2-enoic acid : A monounsaturated fatty acid that is (2E)-hexenoic acid in which the hydrogen at position 3 has been replaced by a methyl group. A malodourous component in the sweat of schizophrenics. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6443739
CHEBI ID144845
SCHEMBL ID195384
MeSH IDM0045983

Synonyms (32)

Synonym
3-methyl-2-hexenoic acid
3-methyl-2e-hexenoic acid
LMFA01030793
CHEBI:144845
27960-21-0
trans-3-methyl-2-hexenoic acid
(2e)-3-methylhex-2-enoic acid
(e)-3-methylhex-2-enoic acid
3-methylhex-2-enoic acid
35205-70-0
EN300-55079
2-hexenoic acid, 3-methyl-, (e)-
q98fu4wj65 ,
unii-q98fu4wj65
tmha
AKOS008113312
3-methyl-2-hexenoic acid, (2e)-
SCHEMBL195384
(2e)-3-methyl-2-hexenoic acid
e-3-methyl-2-hexenoic acid
A1-01430
(e)-3-methyl-2-hexenoic acid
mfcd02258698
AS-58087
A901718
F8880-7277
Q3487540
CS-0072967
EN300-398557
A901147
DTXSID701020850
Z352746820
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
short-chain fatty acidAn aliphatic monocarboxylic acid with a chain length of less than C6. If any non-hydrocarbon substituent is present, the compound is not normally regarded as a short-chain fatty acid.
monounsaturated fatty acidAny fatty acid with one double or triple bond in the fatty acid chain and singly bonded carbon atoms in the rest of the chain. MUFAs have positive effects on the cardiovascular system, and in diabetes treatment.
alpha,beta-unsaturated monocarboxylic acidA monocarboxylic acid in which the carbon of the carboxy group is directly attached to a C=C or C#C bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's2 (22.22)18.2507
2000's4 (44.44)29.6817
2010's1 (11.11)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]